Carmen Lefaucheur
#183,497
Most Influential Person Now
Researcher ORCID ID = 0000-0002-6244-0795
Carmen Lefaucheur's AcademicInfluence.com Rankings
Carmen Lefaucheurcomputer-science Degrees
Computer Science
#11719
World Rank
#12454
Historical Rank
Machine Learning
#5390
World Rank
#5460
Historical Rank
Artificial Intelligence
#5811
World Rank
#5899
Historical Rank
Database
#8802
World Rank
#9240
Historical Rank
Download Badge
Computer Science
Carmen Lefaucheur's Degrees
- Masters Computer Science Stanford University
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Carmen Lefaucheur Influential?
(Suggest an Edit or Addition)Carmen Lefaucheur's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- VEGF inhibition and renal thrombotic microangiopathy. (2008) (890)
- Complement-binding anti-HLA antibodies and kidney-allograft survival. (2013) (738)
- The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative endpoints for next‐generation clinical trials (2018) (709)
- Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. (2010) (696)
- The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology (2016) (509)
- Outcome of Subclinical Antibody‐Mediated Rejection in Kidney Transplant Recipients with Preformed Donor‐Specific Antibodies (2009) (307)
- The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody‐mediated rejection (2020) (283)
- Comparison of Combination Plasmapheresis/IVIg/Anti‐CD20 Versus High‐Dose IVIg in the Treatment of Antibody‐Mediated Rejection (2009) (273)
- Antibody-mediated vascular rejection of kidney allografts: a population-based study (2013) (255)
- Antibody-Mediated Rejection of Solid-Organ Allografts. (2018) (254)
- IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury. (2016) (239)
- Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts. (2015) (235)
- Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. (2006) (214)
- Clinical Relevance of Preformed HLA Donor‐Specific Antibodies in Kidney Transplantation (2008) (200)
- Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients. (2017) (159)
- Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study (2019) (158)
- Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma. (2007) (149)
- Determinants of Poor Graft Outcome in Patients with Antibody‐Mediated Acute Rejection (2007) (147)
- Long term outcomes of transplantation using kidneys from expanded criteria donors: prospective, population based cohort study (2015) (139)
- COVID-19 Infection in Kidney Transplant Recipients: Disease Incidence and Clinical Outcomes. (2020) (127)
- A Simple Clinico‐Histopathological Composite Scoring System Is Highly Predictive of Graft Outcomes in Marginal Donors (2008) (122)
- Real Time Central Assessment of Kidney Transplant Indication Biopsies by Microarrays: The INTERCOMEX Study (2017) (121)
- Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group (2019) (120)
- Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection. (2014) (118)
- Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection (2016) (115)
- Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. (2008) (107)
- Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss. (2017) (106)
- Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypes. (2017) (103)
- Late Failing Heart Allografts: Pathology of Cardiac Allograft Vasculopathy and Association With Antibody‐Mediated Rejection (2016) (102)
- C1 Inhibitor in Acute Antibody‐Mediated Rejection Nonresponsive to Conventional Therapy in Kidney Transplant Recipients: A Pilot Study (2016) (101)
- Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients. (2019) (100)
- Disparities in Acceptance of Deceased Donor Kidneys Between the United States and France and Estimated Effects of Increased US Acceptance (2019) (97)
- Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment. (2017) (87)
- COVID-19 pandemic and worldwide organ transplantation: a population-based study (2021) (82)
- Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis (2018) (71)
- T cell–mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts (2018) (69)
- COVID-19-related medical research: a meta-research and critical appraisal (2021) (67)
- Chemosensitization by erythropoietin through inhibition of the NF-κB rescue pathway (2005) (63)
- Preliminary results of transplantation with kidneys donated after cardiocirculatory determination of death: a French single-centre experience. (2012) (52)
- Dynamic Prognostic Score to Predict Kidney Allograft Survival in Patients with Antibody-Mediated Rejection. (2017) (51)
- Response to treatment and long‐term outcomes in kidney transplant recipients with acute T cell–mediated rejection (2019) (50)
- Value of monitoring circulating donor‐reactive memory B cells to characterize antibody‐mediated rejection after kidney transplantation (2018) (49)
- Renal Histopathological Lesions After Lung Transplantation in Patients with Cystic Fibrosis (2008) (48)
- Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction. (2017) (48)
- Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft Survival. (2019) (43)
- Early Identification of Patients With Out-of-Hospital Cardiac Arrest With No Chance of Survival and Consideration for Organ Donation (2016) (39)
- Mastering the Risk of HLA Antibodies in Kidney Transplantation: An Algorithm Based on Pretransplant Single‐Antigen Flow Bead Techniques (2011) (39)
- Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis. (2017) (36)
- New insights in antibody-mediated rejection (2014) (36)
- Acute Oxalate Nephropathy: A New Etiology for Acute Renal Failure Following Nonrenal Solid Organ Transplantation (2006) (33)
- Complement-binding anti-HLA antibodies are independent predictors of response to treatment in kidney recipients with antibody-mediated rejection. (2018) (31)
- Determinants and Outcomes of Accelerated Arteriosclerosis: Major Impact of Circulating Antibodies. (2015) (27)
- From Humoral Theory to Performant Risk Stratification in Kidney Transplantation (2017) (25)
- Assessment of the Utility of Kidney Histology as a Basis for Discarding Organs in the United States: A Comparison of International Transplant Practices and Outcomes. (2020) (24)
- Trajectories of glomerular filtration rate and progression to end stage kidney disease after kidney transplantation. (2020) (23)
- Update on C1 Esterase Inhibitor (C1-INH) in Human Solid Organ Transplantation. (2019) (22)
- Coordinated Circulating T Follicular Helper and Activated B Cell Responses Underlie the Onset of Antibody-Mediated Rejection in Kidney Transplantation. (2020) (21)
- Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation (2020) (21)
- Biopsie rnale: techniques de prlvement, contre-indications, complications (2006) (21)
- Pulsatile Perfusion Preservation for Expanded-Criteria Donors Kidneys: Impact on Delayed Graft Function Rate (2011) (18)
- [Renal biopsy: procedures, contraindications, complications]. (2006) (18)
- The emerging field of non-HLA-antibodies in transplant medicine and beyond. (2021) (16)
- Kidney Allograft Fibrosis After Transplantation From Uncontrolled Circulatory Death Donors (2015) (16)
- Dynamic prediction of renal survival among deeply phenotyped kidney transplant recipients using artificial intelligence: an observational, international, multicohort study. (2021) (14)
- Survival and specific outcome of sickle cell disease patients after renal transplantation (2019) (11)
- T-bet+CD27+CD21– B cells poised for plasma cell differentiation during antibody-mediated rejection of kidney transplants (2021) (10)
- Determinants and Outcomes of Accelerated ArteriosclerosisNovelty and Significance (2015) (10)
- Evidence for an important role of both complement-binding and noncomplement-binding donor-specific antibodies in renal transplantation (2016) (8)
- Renal Arterial Mycotic Aneurysm After Kidney Transplantation. (2017) (7)
- Lack of impact of pre-emptive deceased-donor kidney transplantation on graft outcomes: a propensity score-based study. (2018) (7)
- Complement-binding anti-HLA antibodies and kidney transplantation. (2014) (6)
- [Role of histaminergic H1 and H2 receptors in prolactin release in humans]. (1982) (5)
- Rejet aigu médié par anticorps (2008) (5)
- Correction: Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis (2018) (5)
- Comparison of machine perfusion versus cold storage in kidney transplant recipients from expanded criteria donors: a cohort-based study. (2020) (5)
- Concomitant loss of regulatory T and B cells is a distinguishing immune feature of antibody-mediated rejection in kidney transplantation. (2022) (5)
- Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report. (2023) (3)
- Anti‐IL‐2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid‐term outcomes after ABO‐incompatible kidney transplantation (2019) (3)
- Desensitization Protocols for Organ Transplantation (2014) (3)
- Recognition of i‐IF/TA as a component of the T cell‐mediated rejection spectrum: Unselected population approach vs random case selection (2018) (3)
- A MULTIDIMENSIONAL PROGNOSTIC SCORE AND NOMOGRAM TO PREDICT KIDNEY TRANSPLANT SURVIVAL: THE INTEGRATIVE BOX (IBOX) SYSTEM (2017) (2)
- Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function. (2015) (2)
- Diagnostic criteria for kidney transplant rejection: a call to action – Authors' reply (2013) (2)
- Exploring the Viability of Kidneys Discarded in the US: A Comparison of Kidney Utilization Patterns and Outcomes in the US and France (2018) (2)
- Adaptive immune cell responses as therapeutic targets in antibody-mediated organ rejection. (2022) (2)
- Clinical recommendations for posttransplant assessment of anti–HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document (2023) (2)
- Identifying the Specific Causes of Kidney Allograft Loss (2018) (2)
- [Antibody-mediated acute rejection]. (2008) (2)
- Molecular Microscope Strategy To Improve Risk Stratification in ABMR.: Abstract# 605 (2014) (2)
- Complement activation in kidney transplantation: from risk stratification to therapeutic strategies (2014) (1)
- Comparison of artificial intelligence and human-based prediction and stratification of the risk of long-term kidney allograft failure (2022) (1)
- Early Recognition of Subclinical Rejection and Outcome of Kidney Allografts.: Abstract# 602 (2014) (1)
- Kidney Allograft Fibrosis After Transplantation From Uncontrolled Circulatory Death Donors.: Abstract# A258 (2014) (1)
- Anti-angiotensin II type 1-receptor antibodies (AT1R-Ab) Induce a Specific Phenotype of Rejection Distinct from HLA antibody-Mediated Rejection (2018) (1)
- Machine learning does not outperform traditional statistical modelling for kidney allograft failure prediction. (2022) (1)
- Addressing The Unmet Need For Precision Diagnosis: Potential Impact of Molecular Assessments On Conventional Biopsy Diagnostics in 41% of 700 Indication Biopsies.: Abstract# 604 (2014) (1)
- Full Oral (2019) (1)
- [Renal biopsy: methods]. (2006) (1)
- Renal allograft rejection: pieces of the puzzle. (2015) (1)
- An automated histological classification system for precision diagnostics of kidney allografts. (2023) (1)
- DSA in solid organ transplantation: is it a matter of specificity, amount, or functional characteristics? (2022) (1)
- Thymoglobulin Induction Decreases risk of ABMR and Death in Kidney Recipients (2018) (1)
- Concurrent Oral Sessions: Heart (2014) (0)
- LBP28: A ROLE FOR IFN-G STIMULATED MONOCYTES IN ANTIBODY-MEDIATED DAMAGE BY C1Q+ DSA (2015) (0)
- Timing of Kidney Clamping and Deceased Donor Kidney Transplant Outcomes (2021) (0)
- KIDNEY TRANSPLANTATION FROM DONATION AFTER CARDIAC DEATH: A FRENCH ACADEMIC HOSPITAL EXPERIENCE: 2199 (2010) (0)
- Defining Response to Standard of Care Treatment of Kidney Recipients with Antibody-Mediated Rejection (2018) (0)
- 336.4: Development and Validation of an Integrative dd-cfDNA System to Predict Allograft Rejection: A Population Based Study (2022) (0)
- SaO015DEFINING RESPONSE TO TREATMENT IN KIDNEY RECIPIENTS WITH ACUTE T CELL-MEDIATED REJECTION (2019) (0)
- Early identification of out-of-hospital cardiac arrest patients with no chance of survival for orientation towards organ donation (2017) (0)
- OR50 Complement-binding donor-specific anti-HLA antibodies induce a specific histo-molecular kidney allograft rejection phenotype (2017) (0)
- Quantitative scoring of progression in transplant glomerulopathy using digital pathology may be superior to Banff cg scoring. (2022) (0)
- Antibody-Mediated Rejection of Solid-Organ Allografts. (2018) (0)
- [Inhibin and cyberning]. (1983) (0)
- 3399Determinants and outcomes of cardiac allograft vasculopathy: major role of donor specific antibody (2018) (0)
- C1q‐Binding DSA Induce Distinct Molecular Phenotypes in Kidney Transplant Biopsies.: Abstract# 2864 (2014) (0)
- 240.1: The Risk of Venous Thromboembolism Is Enhanced After A Cytomegalovirus Infection in Kidney Transplant Recipient (2022) (0)
- [Medication adherence in renal transplantation: evaluation, predictive factors and impact on humoral alloreactivity]. (2022) (0)
- Identifying the Specific Causes and the Determinants of Outcome in Kidney Recipients with Transplant Glomerulopathy: A Multicenter Study (2018) (0)
- The Molecular Phenotype of Antibody‐Mediated Rejection in Heart Transplants.: Abstract# 1374 (2014) (0)
- Dynamic prediction of renal survival using artificial intelligence: an international study of deeply phenotyped cohorts of kidney transplant recipients (2020) (0)
- C1q-binding Donor-Specific Anti-HLA Antibodies for Clinical Decision Making in Kidney Recipients with Antibody-Mediated Rejection Receiving Standard of Care Treatment (2018) (0)
- MO1021: Long-Term Outcomes After Conversion to a Belatacept-Based Immunosuppression in Kidney Transplant: A Matched Cohort Study (2022) (0)
- FC 113: Development and Validation of an Integrative DD-CFDNA System to Predict Allograft Rejection: A Population Based Study (2022) (0)
- SuO016PREDICTORS OF GRAFT FUNCTION IMPROVEMENT AFTER CONVERSION FROM CALCINEURIN INHIBITORS TO BELATACEPT IN KIDNEY RECIPIENTS WITH CALCINEURIN INHIBITOR NEPHROTOXICITY (2019) (0)
- miRNAs as Biomarkers for Heart Transplant Rejection.: Abstract# 1370 (2014) (0)
- P001 Changes in anti-HLA antibody complement-binding capacity reflect the efficacy of antibody-mediated rejection therapy and predict kidney allograft survival (2017) (0)
- Characterization of a Specific Mechanism for Late Loss of Cardiac Allograft: The Role of Antibody‐Mediated Rejection.: Abstract# 680 (2014) (0)
- OR12 Complement-binding donor-specific anti-HLA antibodies predict the response to complement-targeting therapy: A multicenter international study (2017) (0)
- Renal transplantation - clinical studies - 1 (2009) (0)
- Post Transplant DSA: Independent Factor of Accelerated Arteriosclerosis in Kidney Transplant Population.: Abstract# 700 (2014) (0)
- Corrigendum to 'Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report' [American Journal of Transplantation 23 (2023) 133-149]. (2023) (0)
- How to Grade Immunological Risk Using Sensitive HLA Donor-Specific Antibodies Detection Techniques (2010) (0)
- [Inhibin and cybernins]. (1982) (0)
- Validation of an Integrative and Dynamic Prognostic Score for Response to Therapy in Solid Organ Transplants (2018) (0)
- Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN) (2023) (0)
- LONG-TERM OUTCOME ACCORDING TO LEVELS OF PREFORMED DONOR-SPECIFIC HLA-ANTIBODIES IN KIDNEY TRANSPLANTATION: 843 (2010) (0)
- FC 107: Development and Validation of a Machine Learning-Based Virtual Biopsy System in Kidney Transplant Patients (2022) (0)
- Subclinical rejection-free diagnostic after kidney transplantation using blood gene expression. (2023) (0)
- FP761NON-HLA AGONISTIC ANTI-ANGIOTENSIN II TYPE 1 RECEPTOR ANTIBODIES INDUCE A DISTINCTIVE PHENOTYPE OF REJECTION IN KIDNEY TRANSPLANT RECIPIENTS: AN OBSERVATIONAL COHORT STUDY (2019) (0)
- mTOR signaling cascade: novel clinical implications in HLA and non-HLA antibody-mediated vasculopathies? (2022) (0)
- Modeling graft loss in patients with donor‐specific antibody at baseline using the Birmingham‐Mayo (BirMay) predictor: Implications for clinical trials (2019) (0)
- FP766RESPONSE TO TREATMENT IN KIDNEY RECIPIENTS WITH ANTIBODY-MEDIATED REJECTION: A DATA-DRIVEN APPROACH (2019) (0)
- Diagnostic Criteria for Nonviable Pregnancy (2014) (0)
- Abstract 16873: A Human Model of Antibody Mediated Arteriosclerosis And Atherosclerosis (2011) (0)
- Inflammation in Fibrotic Areas (i-IF/TA) Identifies a T cell-mediated Rejection Component of IF/TA with Poor Kidney Allograft Outcome (2018) (0)
- SaO013ARCHETYPE ANALYSIS IDENTIFIES DISTINCT PROFILES IN RENAL TRANSPLANT RECIPIENTS WITH TRANSPLANT GLOMERULOPATHY ASSOCIATED WITH ALLOGRAFT SURVIVAL (2019) (0)
- Molecular Correlates of Endothelial mTOR Activation in Heart Transplant Recipients (2016) (0)
- Inflammation in Scarred Areas (i-IF/TA) (2018) (0)
- Correction (2009) (0)
- Role of C1q-binding donor-specific anti-HLA antibodies in Premature and Accelerated Kidney Allograft Interstitial Fibrosis (2018) (0)
- Immunological Assessment and Monitoring in Kidney Transplantation (2022) (0)
- SaO014ALLOGRAFT GENE EXPRESSION ASSESSMENT PREDICTS GRAFT LOSS IN KIDNEY RECIPIENTS WITH CHRONIC ANTIBODY-MEDIATED REJECTION (2019) (0)
- Natural History and Determinants of Infectious Complications after Kidney Transplantation: A Nationwide Prospective Population Based Cohort (2018) (0)
- Post-Transplant Complement-Binding Donor-Specific Anti-HLA Antibodies Are Strong Predictors of Kidney Allograft Outcome: 900 (2012) (0)
- MO942: Regulatory T and B Cell Responses are Equally Compromised During Antibody-Mediated Rejection of Kidney Allografts (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Carmen Lefaucheur?
Carmen Lefaucheur is affiliated with the following schools:
